Pharmacological Activity of Quercetin and 5 Caffeoylquinic Acid Oral Intake in Male Balb/c Mice with Lung Adenocarcinoma

Arch Med Res. 2020 Jan;51(1):8-12. doi: 10.1016/j.arcmed.2019.11.006. Epub 2020 Feb 18.

Abstract

Background: Lung adenocarcinoma (LAC) is a major worldwide cause of death by cancer, it shows high aggressiveness, functional decline, systemic compromise and severe cachexia, which might be counteracted by dietary redox-active phytochemicals. Therefore, our aim was to establish the anticancer effects of the oral intake of quercetin and 5 caffeoylquinic acid.

Methods: LAC-1-bearing male Balb/c mice received quercetin (0-25 μg/kg/d) and 5 caffeoylquinic acid (0-120 μg/kg/d) for three weeks, with different organic and biochemical variables being then compared with ANOVA and the Fisher Test (p <0.05).

Results: Quercetin delayed 1.18 fold tumour appearance and increased 8.87 fold non-neoplastic body weight gain, whereas 5 caffeoylquinic acid did it in a lesser extent (1.17 and 2.48 fold, respectively), with tumour weight being consequent with the evolution time. Quercetin induced >1.15 fold tumour hydroperoxides and lipoperoxides, whereas 5 caffeoylquinic acid induced only lipoperoxides. Although both phytochemicals reduced <0.85 fold hydroperoxides and lipoperoxides in the kidney, only quercetin was also antioxidant in the liver. Additionally, 5 caffeoylquinic acid increased >1.15 fold hepatic and renal weights. Although these phytochemicals did not modify telencephalic interleukin 6 production, quercetin augmented 2.51 fold interleukin 6 in the diencephalon, whereas 5 caffeoylquinic acid decreased it 0.43 fold.

Conclusions: Quercetin delayed lung adenocarcinoma appearance and increased the non-neoplastic body weight gain in mice with tumour oxidative stress, without brain interleukin 6 participation. 5 caffeoylquinic acid showed similar effects, although they were weaker. Additionally, quercetin acted as a hepatic and renal antioxidant, whereas 5 caffeoylquinic acid only exerted this effect in the kidney. Therefore, safe oral doses of this flavonoid are promissory to modulate lung cancer progression, with further studies being encouraged.

Keywords: 5 caffeoylquinic acid; Cachexia; Cytokine; Lung adenocarcinoma; Oxidative stress; Quercetin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / drug therapy*
  • Adenocarcinoma of Lung / metabolism
  • Adenocarcinoma of Lung / pathology
  • Administration, Oral
  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Body Weight / drug effects
  • Cachexia / drug therapy
  • Cachexia / metabolism
  • Cachexia / pathology
  • Disease Progression
  • Interleukin-6 / blood
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Oxidation-Reduction
  • Oxidative Stress / drug effects
  • Quercetin / administration & dosage*
  • Quercetin / pharmacology
  • Quinic Acid / administration & dosage
  • Quinic Acid / analogs & derivatives*
  • Quinic Acid / pharmacology

Substances

  • Antioxidants
  • Interleukin-6
  • caffeoylquinic acid
  • Quinic Acid
  • Quercetin